CEO Chief Executive Officer
Jilani is a technologist, with a passion for big software delivery. He is recognised in both the media and healthcare sectors as a true innovator, bringing to market many products that were genuinely game changing, but are now established names. Amongst some of his deliveries include the award winning and sector defining BBC iPlayer, the first television business intelligence platform for the WPP Group (Arianna), the first RFID patient tracking system for Great Ormond Street Hospital, revolutionising patient flow and equipment monitoring. Most recently he has been instrumental in delivering Vantage, utilising cutting edge data and technology integration.
As a founding director and CEO, he has helped commercialise Health iQ’s genuine data and technology expertise and develop the overall Health iQ proposition to establish itself as the leader in real world evidence solutions within the market access space. He is regarded as a thought leader within the health-tech space and is regularly consulted for opinions in an advisory capacity.
CIO Chief Information Officer
Yasir is a recognised specialist in healthcare data and informatics, with an industry-wide reputation as one of the leaders in this field. He has worked at director-level across Acute Trust, PCT, Mental Health and SHA organisations, building a broad knowledge of the healthcare data that is second to none. He has led the informatics work on some of the largest projects in recent history, including ‘Healthcare for London’ and the ‘Information Revolution’. He has written in numerous industry publications, providing insight into the use of data in healthcare.
As a founding director of Health iQ, Yasir’s unique insight into ‘Real World Data’ has proven invaluable to a sector that craves data in order to prove outcomes, and helped differentiate the company through its unmatched expertise with data. He has also managed a successful expansion into bespoke development, producing a number of market-leading products such as Vantage, LinQ and PharmaSim.
AD Accounts Director
Rebeka was named Digital Project Manager of the Year at the PM Society Awards 2014 and was instrumental in the development of the Vantage Big Data system. She is a specialist in developing discrete event simulation models and real world evidence studies in a wide range of therapy areas from Respiratory and Immunology to Oncology and Endocrinology. Her successes span modeling oncology pathways for NHS service transformation to developing digital Patient Reported Outcomes Measures for Parkinsons to quantifying the burden of allergic Asthma to designing predictive modeling approaches in CNS to demonstrating the increasing prevalence of Chronic Migraine using real world healthcare data.
She has a 1st class Masters degree in Chemistry from the University of Southampton and currently works with major life science accounts at levels ranging from Global to local affiliate utilising real world evidence for successful pharmaceutical Market Access.
Non-Executive Director / Advisor
Hassan is a founding director and Chief Commercial Officer leading on partnerships and commercial tie ups. He is an expert in developing real world data solutions, having spent many years at the forefront of informatics, public health and commissioning support for the NHS; delivering and trouble-shooting large-scale health intelligence projects at national and regional levels, as well as at Acute and PCT.
He is an Honorary Research Officer at Imperial College, London developing blended learning courses on Big Data, Data Science and eHealth at the Global eHealth Unit. He is also a Lay Advisor to the Royal College of Ophthalmologists advising on areas such as informatics, a member of the Pharmaceutical Health Information Group (PHIG) at the ABPI and a Committee Member of the PM Society.
He is in demand as a public speaker and works with the NHS, medical device and pharmaceutical industry, consulting on challenges that require expertise and insight into health and social care data, its gaps, how to access it, how to add value, and how to construct robust and compelling cases for change.